Con il tuo consenso utilizziamo analisi limitate e rispettose della privacy per capire quali percorsi di ricerca funzionano. Non usiamo tracker pubblicitari né registrazioni delle sessioni. Puoi modificare questa scelta nelle Preferenze. Leggi la Informativa sulla privacy.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
PATH — frequently asked questions
Is UiPath Inc. overvalued?
In our latest published analysis dated 2026-05-10, PATH trades close to fair value. The price recorded at analysis is 10,8 USD versus our fair value of 11,0 USD; the high endpoint is presented separately as potential value of 14,0 USD. That implies roughly 1.8% upside to fair value at that date.
Our latest published report, analyzed 2026-05-10, gives PATH a fair value of 11,0 USD and a potential value of 14,0 USD. The conclusion is triangulated across multiple valuation models and weighted by reliability for UiPath Inc.'s archetype; it is a dated research output, not a live price.
Should I buy PATH now?
Our latest published rating for PATH, analyzed 2026-05-10, is Hold. UiPath Inc. trades close to fair value at the analysis-date price of 10,8 USD versus fair value of 11,0 USD; potential value is 14,0 USD. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for PATH?
The dedicated bear-case section in our report analyzed 2026-05-10 documents UiPath Inc.'s material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is PATH's rating?
Our latest published rating for PATH, analyzed 2026-05-10, is Hold, with a published moat assessment of 6.5/10 (Narrow). It reflects our fair value of 11,0 USD, the potential value of 14,0 USD, and the price recorded at analysis (10,8 USD).
Questo report non è ancora stato tradotto. Aggiorna tra qualche minuto una volta che la coda di traduzione avrà recuperato.
§1 SintesiEN
Risposta in 30 secondiHold
Prezzo rispetto al valore
Prezzo
$10.79
Fair value
$10.98
Valore potenziale
$13.97
Al
Data della quotazione non registrata
Perché può funzionare
Bull: UiPath successfully monetizes its AI agentic platform, re-accelerating top-line growth to double digits and reaching a 30%+ operating margin, fully justifying a $13.97 fair value.
Cosa cambierebbe la nostra valutazione
AI Generative Disruption: Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.
UiPath is a market leader in Robotic Process Automation (RPA) transitioning into a broader AI and process orchestration platform. While top-line growth has decelerated from its hyper-growth phase to high single digits, the company has recently turned profitable, demonstrating the operating leverage inherent in its 83% gross margin profile.
UiPath is a market leader in Robotic Process Automation (RPA) transitioning into a broader AI and process orchestration platform. While top-line growth has decelerated from its hyper-growth phase to high single digits, the company has recently turned profitable, demonstrating the operating leverage inherent in its 83% gross margin profile.
High switching costs embedded deep within enterprise legacy workflows.
Incumbent scale and broad integrations
Incumbent scale and broad integrations in traditional RPA markets.
Cycle upside
Enterprise AI adoption drives massive structural process orchestration needs across sectors.
Raccomandazione interna
Hold. Current valuation fully captures the transition to mature unit economics but lacks a sufficient margin of safety against significant execution and competitive risks.
Panoramica dell’azienda
UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent builder; RPA and API automation; UiPath intelligent xtraction and processing; UiPath test cloud for testing and quality assurance; UiPath packaged and prebuilt agentic solutions; and centralized governance capabilities that apply across automations, AI agents, and manual tasks. It serves the financial services, healthcare, manufacturing, retail, and public sectors. The company was founded in 2005 and is headquartered in New York, New York.
§2 Scenario ribassistaEN
A recessionary enterprise software budget freeze coupled with Microsoft bundling forces drastic pricing cuts. Base case growth of 9% plummets to 0%, while fixed R&D and SBC costs severely destroy GAAP margins.
Microsoft and other hyperscalers aggressively commoditize traditional RPA, stalling UiPath's growth and forcing severe margin compression, dragging fair value down to $8.05.
Come questa tesi può fallire
AI Generative Disruption
Medium
Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.
FV impact
Severe downside toward the FCFF DCF floor of $4.48 per share.
Trigger
12-24 months
Structural Margin Stagnation
High
Segnali di allerta precoce da monitorare
I cinque sviluppi che indebolirebbero la nostra tesi d'investimento.
High switching costs embedded deep within enterprise legacy workflows.
Incumbent scale and broad integrations in traditional RPA markets.
Profitto economico
Economic profit is supported when reported returns exceed the company cost-of-capital hurdle.
6.5/ 10
Narrow
Sources of advantage
01High switching costs embedded deep within enterprise legacy workflows. — High switching costs embedded deep within enterprise legacy workflows.Moderate
02Incumbent scale and broad integrations in traditional RPA markets. — Incumbent scale and broad integrations in traditional RPA markets.Moderate
UiPath successfully monetizes its AI agentic platform, re-accelerating top-line growth to double digits and reaching a 30%+ operating margin, fully justifying a $13.97 fair value.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
Ricavi più recenti1,6 MldCAGR dei ricavi +15,0%
Margine operativo3,5%5 periodi fiscali
Flusso di cassa libero più recente352,2 MlnFY2026
Cassa netta789,9 MlnFY2026
Dettaglio del conto economicoCome la scala aziendale si traduce in utile dichiarato.
StockMarketAgent.AI
Ricavi1,6 MldCosto del venduto−271 MlnUtile lordo1,3 MldCosti operativi−1,3 MldReddito operativo56,8 MlnVoci non operative e imposte+225,6 MlnUtile netto282,3 Mln
Dati della storia finanziaria
Ricavi
1.610.572.000
Costo del venduto
270.984.000
Utile lordo
1.339.588.000
Costi operativi
1.282.828.000
Reddito operativo
56.760.000
Voci non operative e imposte
225.570.000
Utile netto
282.330.000
Panoramica dello stato patrimonialeCome sono detenute e finanziate le attività dichiarate nel periodo selezionato.
PATH trades at 12.0x forward earnings against a peer median of 52.4x; EV/EBITDA of 56.4x against a peer median of 107.7x; 5 peers.
§10 Settore e cicloEN
Fase del ciclo
Expansion
Maturing software phase strictly prioritizing FCF conversion and capital return over growth at all costs.
Ciclo rialzista
Enterprise AI adoption drives massive structural process orchestration needs across sectors.
Ciclo ribassista
Broad IT budget consolidation heavily favors mega-cap incumbents with bundled solutions.
Posizionamento
Maturing software phase strictly prioritizing FCF conversion and capital return over growth at all costs.
§11 Gestione della posizioneEN
Dimensionamento
Hold existing positions. There is currently no margin of safety to initiate new buys at current valuation levels.
Rischio
Trim exposure aggressively if shares approach the $13.97 bull case without a structural re-acceleration in top-line growth.
Tranche di ingresso
Livello
Azione
Perché
Current / pullbacks
Tranche di uscita
Livello
Azione
Thesis break
Trim exposure aggressively if shares approach the $13.97 bull case without a structural re-acceleration in top-line growth.
§12 Prospettive degli investitoriEN
Bull view
Buy
Maintain a Hold rating. The $10.98 compositefair value represents highly accurate pricing of the company's mature compounding trajectory weighed against ongoing execution risks.
Base view
Hold
While the transition to positive free cash flow is highly commendable, the persistent ~18% SBC burden and intense competitive environment heavily cap the upside potential.
§14 Raccomandazione finaleEN
Azione
Mantenere
Maintain a Hold rating. The $10.98 compositefair value represents highly accurate pricing of the company's mature compounding trajectory weighed against ongoing execution risks.
Reassess the thesis against the named valuation, risk, and quarterly checkpoint evidence in this report.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
A breakdown in cash flow conversion indicates that high equity compensation and working capital drag are eroding earnings quality, limiting the self-funded cash generation necessary to repurchase shares and offset dilution.
Attuale:1.315 as of 2026-05-10
Avviso se< 1.000 over two consecutive fiscal quarters
Sustained gross margin degradation reveals severe pricing pressure from bundled cloud orchestrators, eroding the high software gross profit needed to sustain sales distribution and platform development.
Attuale:83.2% for the period ended 2026-01-31
Avviso se< 80.0% over any trailing twelve-month period
Failing to expand operating margins toward steady-state targets proves that organizational overhead is inflexible against competitive pricing, breaking the operating leverage model essential for institutional valuation support.
Attuale:3.5% for the period ended 2026-01-31
Avviso se< 0.0% over two consecutive fiscal quarters
Negative returns on invested capital indicate that generative AI agent substitutes are commoditizing standalone robotic automation workflows, destroying economic value and nullifying the platform's competitive advantage.
Attuale:2.1% as of 2026-05-10
Avviso se< 0.0% over two consecutive fiscal quarters
medium
Monitor
Monitor the threat against the report checkpoints.
The company transitions smoothly to a mature compounder, stabilizing revenue growth at 6-9% while achieving a 25% normalized operating margin over the forecast period.
Warning level: < 1.000 over two consecutive fiscal quarters. A breakdown in cash flow conversion indicates that high equity compensation and working capital drag are eroding earnings quality, limiting the self-funded cash generation necessary to repurchase shares and offset dilution.
Warning level: < 80.0% over any trailing twelve-month period. Sustained gross margin degradation reveals severe pricing pressure from bundled cloud orchestrators, eroding the high software gross profit needed to sustain sales distribution and platform development.
Warning level: < 0.0% over two consecutive fiscal quarters. Failing to expand operating margins toward steady-state targets proves that organizational overhead is inflexible against competitive pricing, breaking the operating leverage model essential for institutional valuation support.
Warning level: < 0.0% over two consecutive fiscal quarters. Negative returns on invested capital indicate that generative AI agent substitutes are commoditizing standalone robotic automation workflows, destroying economic value and nullifying the platform's competitive advantage.
